Trump’s 100% pharma tariffs: How bad will India's pharmaceutical exports be hit? 'Low-cost generic model may offer cushion’
Donald Trump announced 100% tariffs on imported branded or patented pharmaceutical products from October 1, 2025, unless companies build US manufacturing facilities. This policy primarily impacts European nations exporting high-value drugs, while India's generic exports may largely be shielded, though "branded generics" classification remains a concern.
Donald Trump announced 100% tariffs on imported branded or patented pharmaceutical products from October 1, 2025, unless companies build US manufacturing facilities. This policy primarily impacts European nations exporting high-value drugs, while India's generic exports may largely be shielded, though "branded generics" classification remains a concern.
